Unlock instant, AI-driven research and patent intelligence for your innovation.

Use of human rhbdd1 gene and related medicines

A gene and drug technology, applied in the use of human RHBDD1 gene and related drug fields

Active Publication Date: 2016-01-06
SHANGHAI GENECHEM
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, whether the human RHBDD1 gene is related to the apoptosis of tumor cells and its role in tumorigenesis and progression has not been reported in the literature

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of human rhbdd1 gene and related medicines
  • Use of human rhbdd1 gene and related medicines
  • Use of human rhbdd1 gene and related medicines

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0069] Example 1: Preparation of RNAi lentivirus for human RHBDD1 gene

[0070] 1. Screening for effective siRNA targets against the human RHBDD1 gene

[0071] The RHBDD1 (NM_032276) gene information was retrieved from Genbank; effective siRNA targets for the RHBDD1 gene were designed using the design software Genechem of Shanghai Jikai Gene Chemical Technology Co., Ltd. In the coding sequence (CDS) region of the RHBDD1 gene, a sequence of 33 bases was obtained starting from every other base, and Table 1 lists 33 effective siRNA target sequences for the RHBDD1 gene.

[0072] Table 1 is targeted at the siRNA target sequence of human RHBDD1 gene

[0073]

[0074]

[0075] Aiming at the siRNA target (taking SEQIDNO: 21 as an example), the double-stranded DNA Oligo sequence (table 2) containing AgeI and EcoRI restriction endonuclease at both ends of synthesis; Act on pGCSIL-GFP carrier with AgeI and EcoRI restriction enzyme Provided by Shanghai Jikai Gene Chemical Technolo...

Embodiment 2

[0093] Example 2: Real-time fluorescent quantitative RT-PCR method to detect the silencing efficiency of RHBDD1 gene

[0094] Human liver cancer HepG2 cells in logarithmic growth phase, human tongue squamous cell carcinoma Tca8113 cells, human breast cancer MCF-7 cells, human pancreatic cancer Panc-1 cells, human gastric cancer SGC7901 cells and human lung cancer 95D cells were trypsinized, Make a cell suspension (the number of cells is about 5×10 4 / ml) were inoculated in a 6-well plate and cultured until the cell confluency reached about 30%. According to the multiplicity of infection (the MOI of Tca8113, HepG2 cells, Panc-1 cells and 95D cells is 10, the MOI of SGC7901 cells and MCF-7 is 20) value, add an appropriate amount of the virus prepared in Example 1, and replace after culturing for 24 hours After the infection time reached 4 days, the cells were collected. Total RNA was extracted according to the instruction manual of Invitrogen's Trizol. According to the M-MLV ...

Embodiment 3

[0102] Example 3: Detection of proliferation ability of tumor cells infected with RHBDD1-shRNA lentivirus

[0103] Human liver cancer HepG2 cells in logarithmic growth phase, human tongue squamous cell carcinoma Tca8113 cells, human breast cancer MCF-7 cells, human pancreatic cancer Panc-1 cells, human gastric cancer SGC7901 cells and human lung cancer 95D cells were trypsinized, Make a cell suspension (the number of cells is about 5×10 4 / ml) were inoculated in a 6-well plate and cultured until the cell confluency reached about 30%. According to the multiplicity of infection (the MOI of Tca8113, HepG2 cells, Panc-1 cells and 95D cells is 10, the MOI of SGC7901 cells and MCF-7 is 20), add an appropriate amount of RHBDD1-shRNA lentivirus, and replace the medium after culturing for 24 hours , after the infection time reached 4 days, the cells of each experimental group in the logarithmic growth phase were collected. The complete medium was resuspended into a cell suspension (2...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of a human RHBDD1 gene and drugs related to the gene. The invention discloses applications of the human RHBDD1 gene in oncotherapy, tumor diagnosis and drug preparation. The invention further constructs human RHBDD1 gene micromolecule interference ribonucleic acid (RNA), a human RHBDD1 gene interference nucleic acid construction body, a human RHBDD1 gene interference slow virus and discloses the functions. The si RNA or the nucleic acid construction body including the si RNA and the slow virus can restrain the human RHBDD1 from expressing, especially the slow virus, can efficiently infect target cells, can high-efficiently restrain the PRBDD1 of the target cells from expressing, furthermore restrain the growth of tumor cells, promote apoptosis of the tumor cells and have great significances in the tumor treatment.

Description

technical field [0001] The invention relates to the field of biotechnology, and more specifically relates to the use of human RHBDD1 gene and related medicines. Background technique [0002] RNA interference (RNA interference, RNAi) is a conservative defense mechanism in biological evolution, first discovered in 1998 (FireA, XuS, MontgomeryMK, KostasSA, DriverSE, MelloCC. Potentandspecificgeneticinterferencebydouble-strandedRNAinCaenorhabditiselegans.Nature.1998; -11.). Its essence is the specific degradation of its homologous mRNA mediated by double-stranded RNA, thereby inhibiting the process of corresponding gene expression. Because of its exact gene suppression effect, cascade amplification effect and high penetration, it has a good application prospect in the study of malignant tumors (AngajiSA, HedayatiSS, PoorRH, MadaniS, PoorSS, PanahiS.ApplicationofRNAinterferenceintreatinghumandiseases.JGenet .2010;89(4):527-37.). Studies have shown that small interfering RNA (s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K48/00C12N15/113C12N15/11C12N15/63C12N7/01C12Q1/68A61P35/00
Inventor 朱向莹韩海雄孙琴谭畅杨敏高博沈浩金杨晟瞿红花曹跃琼
Owner SHANGHAI GENECHEM